<bill session="109" type="h" number="729" updated="2013-07-19T19:10:38-04:00">
  <state datetime="2005-02-09">REFERRED</state>
  <status>
    <introduced datetime="2005-02-09"/>
  </status>
  <introduced datetime="2005-02-09"/>
  <titles>
    <title as="introduced" type="short">Medicare Drug Cost Credibility Act of 2005</title>
    <title as="introduced" type="official">To assure cost credibility of the Medicare prescription drug benefit.</title>
  </titles>
  <sponsor id="400387"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2005-02-09">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2005-02-09">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2005-02-09">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2005-03-08">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="2005-03-22">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Cost accounting"/>
    <term name="Cost control"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Finance and financial sector"/>
    <term name="Government operations and politics"/>
    <term name="Government spending reductions"/>
    <term name="Medicare"/>
    <term name="Prescription pricing"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>2/9/2005--Introduced.
Medicare Drug Cost Credibility Act of 2005 - Provides that, if the net mandatory outlays for the Medicare prescription drug benefit for a fiscal year exceed the original Congressional Budget Office estimate of such benefit for that fiscal year, the Secretary of Health and Human Services shall utilize negotiating authority in order to reduce the acquisition cost for prescription drugs.</summary>
</bill>
